Samaritan Pharmaceuticals is touting animal studies showing that its cardio drug SP-1000 reduces cholesterol levels. Testing genetically engineered animals, researchers said that the pre-clinical studies demonstrated the drug's ability to reduce "bad" cholesterol.
- read the press release for more